A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Carcinoma Breast Stage IV
Interventions: DRUG: Pembrolizumab|DRUG: Carboplatin|DRUG: Gemcitabine
Sponsor: Fox Chase Cancer Center
Collaborators: University of Wisconsin, Madison